Zinzino Preliminary Sales Report July 2026

August 11, 2026
Press Release

Zinzino group revenue increased with a total of 20%, compared with the previous year.

GOTHENBURG, Sweden – The revenue in July for Zinzino‘s sales markets increased by 20% and amounted to SEK 313.4 (261.6) million. Faun Pharma’s external sales amounted to SEK 2.5 (2.2) million.

Overall, the Group increased revenues by 20% to SEK 315.9 (263.8) million compared with the previous year.

Accumulated revenue for January – July 2026 increased by 22% to SEK 2,174.8 (1,782.0) million.

Revenues were distributed as follows:

Regions,MSEK	26-Jul	25-Jul	Change	YTD 2026	YTD 2025	Change
The Nordics	24.5	26.1	-6 %	182.2	181.5	0 %
Central Europe	98.1	76.7	28 %	655.8	491.8	33 %
East Europe	27.4	31.6	-1 %	193.7	218.1	-11 %
South & West Europe	49.9	47.2	6 %	357.2	309.2	16 %
The Baltics	8.7	10.0	-13 %	65.2	66.7	-2 %
North America	64.4	47.2	36 %	465.8	294.7	58 %
South America	3.9	0.8	388 %	26.6	5.6	375 %
Asia-Pacific	34.3	20.1	71 %	176.4	169.1	4 %
Africa	2.2	1.9	16 %	14.5	12.1	20 %
Zinzino	313.4	261.6	20 %	2,137.4	1,748.8	22 %
Faun Pharma	2.5	2.2	14 %	37.4	33.2	13 %
Zinzino Group	315.9	263.8	20 %	2,174.8	1,782.0	22 %

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
South America: Peru, Colombia
Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
Africa: South Africa

About Zinzino

Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market.

Zinzino’s scientifically proven nutritional supplements are available in more than 100 markets across the world. Zinzino has acquired all assets in the health and wellness companies It Works!, Enhanzz Global, Truvy, Bodē Pro, Valentus, Zurvita and Xelliss, and Sanki Global. The company co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns the Swiss biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters are in Gothenburg, Sweden, with additional offices in Europe, Asia, and Australia. For more information, please visit www.zinzino.com

Source: Zinzino

Get more information, facts and figures about Zinzino, click here for the Zinzino overview.

Disclaimer: At BFH, we strive to keep all content—articles, press releases, data—as accurate and current as possible at time of publishing. However, treat this content as a guide, not as definitive authority for business decisions. Publishing a press release does not imply Business For Home BV endorses a company or individual, nor guarantees its claims. No warranties or representations, expressed or implied, are made regarding the accuracy, completeness, or suitability of information provided on this website. All content is provided “as-is,” without liability for errors or usage. Always fact-check and conduct your own due diligence. BFH publishes press releases for the global Direct Selling / Network Marketing / Home Business community. Laws governing Direct Selling can vary greatly by country; BFH does not warrant that any company or content is in full compliance with various local or country-specific laws; it’s up to the reader to research, verify and comply with all applicable local regulations.

Maurizio Conti